Curis, Inc. (CRIS)
1.35
+0.10
(+8.00%)
USD |
NASDAQ |
Dec 04, 16:00
1.33
-0.02
(-1.48%)
After-Hours: 20:00
Curis Total Liabilities (Quarterly): 42.33M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 514.76M |
| Halozyme Therapeutics, Inc. | 1.717B |
| AIM ImmunoTech, Inc. | 11.57M |
| Protalix Biotherapeutics, Inc. | 29.36M |
| Armata Pharmaceuticals, Inc. | 185.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.64M |
| Shareholders Equity (Quarterly) | -14.69M |
| Debt to Equity Ratio | -2.083 |
| Current Ratio | 0.6984 |
| Net Debt Paydown Yield | 10.71% |